IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 423.30K | 330.50K | 249.70K | 204.70K | 264.70K |
| Total Other Revenue | -- | -- | 100.00 | 100.00 | 100.00 |
| Total Revenue | 423.30K | 330.50K | 249.80K | 204.80K | 264.80K |
| Cost of Revenue | 685.10K | 601.40K | 608.00K | 1.33M | 1.35M |
| Gross Profit | -261.80K | -270.90K | -358.30K | -1.13M | -1.09M |
| SG&A Expenses | 3.12M | 2.97M | 2.61M | 3.30M | 4.65M |
| Depreciation & Amortization | 274.50K | 376.20K | 473.20K | 1.81M | 1.31M |
| Other Operating Expenses | 4.38M | 4.77M | 5.21M | 6.43M | 6.66M |
| Total Operating Expenses | 9.28M | 9.82M | 10.22M | 14.10M | 16.22M |
| Operating Income | -8.86M | -9.49M | -9.97M | -13.89M | -15.96M |
| Income Before Tax | -8.70M | -9.77M | -9.80M | -10.85M | -8.50M |
| Income Tax Expenses | 0.00 | -44.70K | -42.30K | -164.30K | -164.30K |
| Earnings from Continuing Operations | -8.70 | -9.72 | -9.76 | -10.68 | -8.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.70M | -9.72M | -9.76M | -10.68M | -8.33M |
| EBIT | -8.86M | -9.49M | -9.97M | -13.89M | -15.96M |
| EBITDA | -8.25M | -8.79M | -9.16M | -11.66M | -13.63M |
| EPS Basic | -0.16 | -0.21 | -0.15 | -0.80 | -0.34 |
| Normalized Basic EPS | -0.07 | -0.09 | -0.06 | -0.73 | -0.45 |
| EPS Diluted | -0.16 | -0.21 | -0.16 | -0.80 | -0.35 |
| Normalized Diluted EPS | -0.07 | -0.09 | -0.06 | -0.73 | -0.45 |
| Average Basic Shares Outstanding | 225.70M | 183.46M | 1.00B | 961.05M | 922.08M |
| Average Diluted Shares Outstanding | 225.70M | 183.46M | 1.00B | 961.06M | 922.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |